Ten Myths About GLP-1 Medication

1. "It is the easy way out"

This is the one that keeps people from asking their doctor, so it goes first. Nobody says a person with high blood pressure took the easy way out by treating it. Obesity has a measurable physiology — appetite signalling, set point defence, metabolic adaptation — and treating that physiology is medicine, not shortcut.

It is also not passive. The people who do best still eat protein deliberately, train twice a week, and stick with it through a plateau. The medication removes an obstacle. It does not do the work. What it actually changes is described in Why GLP-1 Medication Quiets the Food Noise, and how it stacks up against the alternatives is in GLP-1 Medication vs. Diet Programmes and GLP-1 Medication vs. Bariatric Surgery.

2. "You will just gain it all back"

Partly true, and worth taking seriously. The STEP 4 trial found people who stopped semaglutide regained about two-thirds of their lost weight within a year. That is real and we say so plainly.

What is false is the implication that this makes treatment pointless. The same is true of blood pressure medication, and nobody concludes from that it should not be taken. The answer is a maintenance plan rather than an abrupt stop — the whole subject of Maintenance: Keeping the Weight Off.

3. "It destroys your metabolism"

False, and backwards. Metabolic adaptation — a lower resting rate after weight loss — happens with *every* method of losing weight, and it is driven mostly by having less body mass and less muscle. GLP-1 medication does not cause it beyond what the weight loss itself explains.

What does protect metabolic rate is keeping muscle, which is entirely within your control. Protecting Muscle While You Lose Fat, and the full mechanism in What Weight Loss Does to Your Metabolism.

4. "Ozempic face"

Half-true, and misattributed. Facial volume loss is a consequence of losing a significant amount of weight, at any speed, by any method. Lose thirty pounds through surgery, diet or medication and your face changes.

What is fair within it: GLP-1 makes rapid loss much easier to achieve, so more people experience it and experience it faster. A moderate pace, adequate protein and preserved muscle all reduce it. The same applies to loose skin elsewhere on the body — see Loose Skin After Weight Loss.

5. "It is only for diabetics"

False. The class began in diabetes care, which is where the name recognition comes from. But the weight-management trials — STEP 1, SURMOUNT-1, SELECT — enrolled people *without* diabetes specifically, and produced the headline results in that population. See The Complete Guide to GLP-1 Medications.

6. "Compounded medication is fake"

False, but the real picture has nuance. Compounded preparations contain the same active ingredient, prepared by licensed pharmacies under state or federal oversight, from FDA-registered ingredient sources. That is ordinary pharmacy practice.

What is genuinely different: a compounded preparation is not itself an FDA-approved finished product, and there is no manufacturer trial of that specific preparation. That distinction is real, and we set it out at length rather than glossing it in Compounded GLP-1 Medication, Explained. What *is* fake is 'research grade' peptide sold online without a prescription — which is a different thing entirely, and dangerous.

7. "The side effects are unbearable"

Mostly false, and largely preventable. Most side effects are mild, digestive, concentrated around dose increases, and fade with adaptation. The severe experiences people describe online are heavily weighted toward escalating too fast — which the titration schedule in GLP-1 Dosing and Titration, Week by Week exists to prevent.

Serious complications are uncommon, and screening before you start is what keeps them that way. The practical management is in Managing GLP-1 Side Effects.

8. "You have to be on it forever"

Not necessarily — but plan as though you might be. Many people move to a lower maintenance dose long-term. Some taper off with physician guidance and hold their weight. What reliably fails is stopping abruptly with no plan and no follow-up.

9. "It causes thyroid cancer"

Not established in humans. The warning comes from rodent studies in which sustained GLP-1 exposure caused thyroid C-cell tumours in rats. Rodent thyroid physiology differs substantially from human, and the effect has not been demonstrated in people.

Because the possibility is not fully excluded, these medications are contraindicated for anyone with a personal or family history of medullary thyroid carcinoma or MEN2. That is a specific, narrow exclusion — and it is why your family history is part of the screening.

10. "It is just an appetite suppressant"

False, and it undersells what is happening. Older appetite suppressants worked by stimulation — they made you wired and you ate less as a side effect. GLP-1 restores a satiety signal your body is supposed to produce, and it acts on blood sugar, gastric emptying, glucagon and vascular inflammation at the same time.

The 20% reduction in cardiovascular events found in SELECT is not something an appetite suppressant does. GLP-1 Benefits Beyond the Scale covers the rest.